TEVA PHARMACEUTICAL FINANCE II B.V., as Issuer TEVA PHARMACEUTICAL INDUSTRIES LIMITED, as Guarantor and THE BANK OF NEW YORK MELLON, as Trustee SENIOR INDENTURE Dated as of June 18, 2010Teva Pharmaceutical Industries LTD • June 18th, 2010 • Pharmaceutical preparations • New York
THIS INDENTURE, dated as of June 18, 2010 among Teva Pharmaceutical Finance II B.V., a Netherlands Antilles private limited liability company (the “Issuer”), Teva Pharmaceutical Industries Limited, a corporation incorporated under the laws of Israel (the “Guarantor”), and The Bank of New York Mellon, a New York banking corporation (the “Trustee”),
TEVA PHARMACEUTICAL FINANCE III, LLC, as Issuer TEVA PHARMACEUTICAL INDUSTRIES LIMITED, as Guarantor and THE BANK OF NEW YORK MELLON, as Trustee SENIOR INDENTURE Dated as of June 18, 2010Indenture • June 18th, 2010 • Teva Pharmaceutical Industries LTD • Pharmaceutical preparations • New York
THIS INDENTURE, dated as of June 18, 2010 among Teva Pharmaceutical Finance III, LLC, a Delaware limited liability company (the “Issuer”), Teva Pharmaceutical Industries Limited, a corporation incorporated under the laws of Israel (the “Guarantor”), and The Bank of New York Mellon, a New York banking corporation (the “Trustee”),
TEVA PHARMACEUTICAL FINANCE III, LLC, as Issuer TEVA PHARMACEUTICAL INDUSTRIES LIMITED, as Guarantor and THE BANK OF NEW YORK MELLON, as Trustee FIRST SUPPLEMENTAL SENIOR INDENTURE Dated as of June 18, 2010 to the Senior Indenture dated as of June 18,...First Supplemental Senior Indenture • June 18th, 2010 • Teva Pharmaceutical Industries LTD • Pharmaceutical preparations • New York
FIRST SUPPLEMENTAL SENIOR INDENTURE, dated as of June 18, 2010, among Teva Pharmaceutical Finance III, LLC, a Delaware limited liability company (the “Issuer”), Teva Pharmaceutical Industries Limited, a corporation incorporated under the laws of Israel (the “Guarantor”), and The Bank of New York Mellon, a New York banking corporation, as trustee (the “Trustee”),
